Synaptive and General Atlantic Attend OBIO Summit on future of Canadian Health Science Innovation
Synaptive Medical attended the Ontario Bioscience Innovation Organization’s (OBIO®) summit on January 23, 2017. The summit brought together industry, academic, government and investment leaders to discuss the future of health science innovation in Canada. Cameron Piron, president and co-founder of Synaptive Medical, and David Caluori, principal of General Atlantic, were among the keynote presenters.
“Synaptive Medical is proud to be an Ontario-based medical device and technology company growing our R&D, manufacturing and corporate headquarters here in Canada,” said Piron. “Since our founding in 2012, we’ve expanded from six people to approximately three hundred employees across North America and launched eight commercial products in three countries. With General Atlantic as our equity partner, we’re scaling our international expansion and exporting Canadian know-how to the world. There’s never been a more exciting time for Ontario’s life sciences and medical technology ecosystem.”
“General Atlantic is dedicated to helping businesses scale and grow to new levels,” said Caluori. “We are proud to be working with Canadian anchor companies like Synaptive Medical, as we recognize the assets and investment opportunities available in Canada. The OBIO Leadership Summit has brought together Health Science leaders from Ontario and Canada who embrace a culture of entrepreneurship, partnership and act as active champions to better the domestic economy and we look forward to evaluating future investment opportunities with Canadian companies.”
“This Summit is a great opportunity to discuss the challenges, successes, and the future of bioscience in Ontario. Our shared goal to grow our life science companies, entrepreneurs, and scale ups can only be reached by working together,” said the Honourable Reza Moridi, Minister of Research, Innovation and Science.